KORU Medical Systems (KRMD) Cash from Financing Activities (2010 - 2026)
KORU Medical Systems (KRMD) posted quarterly Cash from Financing Activities of -$29216.0 for Q1 2026, up 81.83% year-over-year from -$16067.6 in Q1 2025, and up 88.97% quarter-over-quarter from -$264908.0 in Q4 2025.
KORU Medical Systems (KRMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has reported Cash from Financing Activities for 11 consecutive years, with -$29216.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 81.83% year-over-year to -$29216.0; the TTM figure through Mar 2026 stood at -$89758.0 (up 60.5% YoY), while the FY2025 annual figure was -$221350.0, up 10.94% from the prior year.
- Cash from Financing Activities rose to -$29216.0 in Q1 2026 per KRMD's latest filing, from -$264908.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $940282.0 in Q3 2022 and bottomed at -$264908.0 in Q4 2025.
- Historically, Cash from Financing Activities has averaged -$25793.0 across 5 years, with a median of -$182120.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 32154.12% — and 2026, when it jumped 81.83%.
- KORU Medical Systems' Cash from Financing Activities stood at -$145603.0 in 2022, then dropped by 22.49% to -$178355.0 in 2023, then dropped by 20.95% to -$215716.0 in 2024, then declined by 22.8% to -$264908.0 in 2025, then surged by 88.97% to -$29216.0 in 2026.
- Business Quant data shows KRMD's Cash from Financing Activities at -$29216.0 in Q1 2026, -$264908.0 in Q4 2025, and $396330.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | KORU Medical Systems | 149.08 Mn | 140.78 Mn | 7.85 Mn | -118,816.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -118,816.00 |
| Jun 30, 2026 | -118,816.00 |
| Mar 31, 2026 | -29,216.00 |
| Mar 31, 2026 | -29,216.00 |
| Dec 31, 2025 | -264,908.00 |
| Dec 31, 2025 | -264,908.00 |
| Sep 30, 2025 | 396,330.00 |
| Sep 30, 2025 | 396,330.00 |
| Jun 30, 2025 | -191,964.00 |
| Jun 30, 2025 | -191,964.00 |
| Mar 31, 2025 | -160,808.00 |
| Mar 31, 2025 | -160,808.00 |
| Dec 31, 2024 | -215,716.00 |
| Dec 31, 2024 | -215,716.00 |
| Sep 30, 2024 | 374,454.00 |
| Sep 30, 2024 | 374,454.00 |
| Jun 30, 2024 | -225,151.00 |
| Jun 30, 2024 | -225,151.00 |
| Mar 31, 2024 | -182,120.00 |
| Mar 31, 2024 | -182,120.00 |